Privacy-First Advertising in Healthcare: How to Navigate Sensitive Data Without Losing Performance
Health-related data has become one of the most valuable, and most scrutinized, categories in digital advertising.
For marketers, advertisers, publishers, and AdTech partners, the opportunity is clear: more relevant messaging, stronger engagement, and better campaign performance. But the compliance stakes have never been higher. Between the growing patchwork of state privacy laws, heightened scrutiny around health-related inferences, and continued FTC enforcement, the old ways of activating and measuring sensitive audiences are no longer enough.
That is exactly why we created our latest white paper: Privacy-First Advertising: Compliant Strategies for Sensitive Health Conditions Data in the AdTech Ecosystem
This new resource explores how organizations can continue to reach health-related audiences responsibly, without overexposing sensitive personal information or relying too heavily on consent-only approaches that often limit scale.
Why this matters now
Health conditions data, treatment signals, and even behavioral inferences can now trigger heightened obligations under a growing number of state privacy laws. As more states classify health-related data as sensitive, brands and their partners are being forced to rethink how they handle onboarding, identity resolution, audience activation, and measurement.
At the same time, marketers still need performance. They still need scale. And they still need to prove ROI.
That tension is exactly what this white paper addresses.
Rather than framing privacy and performance as opposing forces, the paper outlines a more practical path forward, one built around privacy-by-design strategies that support both responsible data use and business outcomes.
What you’ll learn in the white paper
The current U.S. regulatory landscape for sensitive health-related data in advertising
Why consent remains important, but often is not the most scalable standalone solution
The risks associated with traditional onboarding, identity resolution, and pixel-based measurement workflows
How privacy-enhancing technologies like tokenization, clean rooms, and de-identification can reduce exposure while preserving utility
Why demographic and modeled audience strategies are becoming an increasingly important part of compliant health advertising
How industry guidance from NAI, IAPP, and IAB Tech Lab can help shape a more defensible strategy
A smarter way to think about health data
One of the biggest takeaways from the paper is that health-related data sensitivity is not always black and white. Context matters. Intended use matters. Consumer expectations matter.
That is why a one-size-fits-all approach no longer works. Organizations need a more flexible framework, one that can help them evaluate risk, reduce unnecessary exposure, and still move campaigns forward with confidence.
Moving beyond consent-only strategies
Consent will continue to play an important role in privacy compliance. But for many organizations operating across multiple states, consent-only models can introduce friction, reduce match rates, and make national campaign execution far more difficult.
This white paper explores how layered strategies can help solve for that.
By combining consent where required with privacy-enhancing technologies and modeled approaches, advertisers can build campaigns that are more scalable, more privacy-conscious, and better aligned with the realities of today’s regulatory environment.
Built for advertisers navigating real-world complexity
This is not a theoretical overview. It is a practical guide for organizations trying to operate in a fast-changing environment where health-related advertising demands both care and precision.
Whether you are focused on audience activation, identity resolution, pixel strategy, campaign measurement, or partner risk, this white paper provides a useful framework for thinking through the next phase of privacy-forward advertising.
If your organization is working with health-related data, or even health-related inferences, now is the time to take a closer look at how your advertising strategy is evolving.